Nang Kuang Pharmaceutical Co., Ltd.
1752.TW
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.36B
Close$
Share Statistics
| Market cap | $3.36 Billion |
|---|---|
| Enterprise Value | $3.68 Billion |
| Dividend Yield | $1.60 (4.81%) |
| Earnings per Share | $2.42 |
| Beta | 0.14 |
| Outstanding Shares | 99,963,000 |
Return
| Return on Equity | 8.46% |
|---|---|
| Return on Assets | 5.17% |
| Return on Invested Capital | 9.62% |
Valuation & Multiples
| P/E Ratio | 16.38 |
|---|---|
| PEG | -4384.84 |
| Price to Sales | 1.58 |
| Price to Book Ratio | 1.39 |
| Enterprise Value to Revenue | 1.74 |
| Enterprise Value to EBIT | 13.66 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$0.60
Average shareholder expectationRevenue Estimate
$468.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$0.60
Average shareholder expectationRevenue Estimate
$468.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Nang Kuang Pharmaceutical Co., Ltd.
552 employees
CEO: Yu-Bei Wang Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a pharmaceutical enterprise. Its comprehensive product range includes various sterile injectable forms such as parenterals, aseptic parenterals, lyophilized inje...